José Trevejo
Net worth: 72 505 $ as of 2024-04-29
Profile
José Miguel Trevejo was the founder of SmartPharm Therapeutics, Inc. founded in 2017, where he held the title of Director from 2017 to 2019.
He worked as a Medical Director at Genentech, Inc. from 2013 to 2014 and at Vertex Pharmaceuticals (Canada), Inc. from 2010 to 2013.
He was also the Head-Clinical Development & Regulatory Affairs at Visterra, Inc. and the Principal Investigator & Scientist at The Charles Stark Draper Laboratory, Inc. He held the position of Chief Development Officer at Rocket Pharmaceuticals, Inc. and Vice President-Clinical Development at Cyclerion Therapeutics, Inc. He was the Director at Diabetes Hands Foundation.
He will be the Chief Medical Officer at Tarsus Pharmaceuticals, Inc. from 2022 to 2024.
Dr. Trevejo received his undergraduate degree from the University of California, Los Angeles and his doctorate from Weill Cornell Medical College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-12-19 | 2,251 ( 0.01% ) | 72 505 $ | 2024-04-29 |
Former positions of José Trevejo
| Companies | Position | End |
|---|---|---|
| TARSUS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2024-01-17 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | 2014-07-31 |
Vertex Pharmaceuticals (Canada), Inc.
 Vertex Pharmaceuticals (Canada), Inc. Miscellaneous Commercial ServicesCommercial Services Vertex Pharmaceuticals (Canada), Inc. operates as a biotechnology company that invests in scientific innovation to create medicines for people with serious and life-threatening diseases. It discovered medicines to treat the cause of cystic fibrosis a genetic disease. The company is headquartered in Toronto, Canada. | Chief Tech/Sci/R&D Officer | 2013-01-31 |
| CYCLERION THERAPEUTICS, INC. | Corporate Officer/Principal | - |
| ROCKET PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Training of José Trevejo
| University of California, Los Angeles | Undergraduate Degree |
| Weill Cornell Medical College | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| TARSUS PHARMACEUTICALS, INC. | Health Technology |
| ROCKET PHARMACEUTICALS, INC. | Health Technology |
| CYCLERION THERAPEUTICS, INC. | Health Technology |
| Private companies | 6 |
|---|---|
Visterra, Inc.
 Visterra, Inc. Pharmaceuticals: MajorHealth Technology Visterra, Inc. Is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of antibody-based therapies for kidney diseases, and other chronic diseases. It focuses on its research technology platform, HIEROTOPE technology. The company was founded by Alan L. Crane, Kevin J. Bitterman and Ram Sasisekharan on December 20, 2007 and is headquartered in Waltham, MA. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Vertex Pharmaceuticals (Canada), Inc.
Vertex Pharmaceuticals (Canada), Inc. Miscellaneous Commercial ServicesCommercial Services Vertex Pharmaceuticals (Canada), Inc. operates as a biotechnology company that invests in scientific innovation to create medicines for people with serious and life-threatening diseases. It discovered medicines to treat the cause of cystic fibrosis a genetic disease. The company is headquartered in Toronto, Canada. | Commercial Services |
The Charles Stark Draper Laboratory, Inc.
 The Charles Stark Draper Laboratory, Inc. Miscellaneous Commercial ServicesCommercial Services The Charles Stark Draper Laboratory, Inc. engages in the design, development, and deployment of technological solutions. It focuses on the areas of commercial, space, national security, strategic systems, and global challenges. It provides engineering services to government, commercial companies, and educational institutions. The company was founded by Charles Stark Draper in 1934 and is headquartered in Cambridge, MA. | Commercial Services |
Diabetes Hands Foundation
 Diabetes Hands Foundation Miscellaneous Commercial ServicesCommercial Services Diabetes Hands Foundation is non profit organization which provides support and medical assistance for diabetes. It offers programs that provide social support information, promote diabetes awareness, and improves the lives of people living with diabetes. The company is headquartered in Berkeley, Canada. | Commercial Services |
SmartPharm Therapeutics, Inc.
 SmartPharm Therapeutics, Inc. BiotechnologyHealth Technology SmartPharm Therapeutics, Inc. engages in the development of next-generation, non-viral gene therapies for the treatment of serious or rare diseases. Its pipeline include Gene MAbs for SARS-Cov-2, enzyme replacement therapy, and cell and tissue restoration. The company was founded by José Trevejo in 2017 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- José Trevejo
